The Debate Has Real Stakes

The question of whether ADHD is overdiagnosed sounds like an academic dispute. It is not. The answer has direct implications for whether millions of people receive care they need, whether children carry stigma for traits that are simply variations in learning style, and whether the pharmaceutical industry has successfully pathologized ordinary human behavior for profit. Both the overclaiming and the underclaiming positions in this debate cause harm. Getting it right matters. The data does not point in a single direction, which is part of what makes the debate so persistent.

What the Numbers Actually Show

Diagnosis rates for ADHD have increased substantially over the past three decades in most high-income countries. In the United States, the CDC estimates that roughly 9-10% of children have received an ADHD diagnosis, up from approximately 3% in the early 1990s. Similar trends are visible in Australia, Canada, the UK, and across Western Europe, though at lower rates. The question is what to make of this increase. Several explanations are not mutually exclusive. Genuine awareness has improved among clinicians and families, reducing underdiagnosis that was real. Diagnostic criteria have expanded, capturing a broader population. Pharmaceutical companies have engaged in aggressive marketing to physicians and consumers. Structural pressures in educational and professional environments have increased, making ADHD traits more costly and therefore more likely to be identified and addressed. And some proportion of the increase may represent genuine pathologizing of traits that do not rise to the level of clinical impairment. Research from King's College London examining diagnostic rate variation across regions within England found a fourfold difference in ADHD diagnosis rates between the highest- and lowest-diagnosing areas, with no corresponding differences in measures of population health or behavioral outcomes. This geographic variation is difficult to explain by anything other than diagnostic inconsistency — some areas are applying criteria significantly more broadly than others.

The Underdiagnosis Problem Is Also Real

The overdiagnosis argument often overlooks the evidence for systematic underdiagnosis that coexists with the evidence for overdiagnosis. Women and girls have historically been diagnosed at far lower rates than men and boys, not because ADHD is less prevalent in females, but because the diagnostic criteria were developed primarily from research on male children who present with more externalized, hyperactive symptoms. Women more often present with inattentive-type symptoms that are less disruptive in classroom settings and therefore less likely to trigger a referral. Adults were similarly underserved for decades. ADHD was classified as a childhood disorder well into the 1990s despite evidence that symptoms persisted into adulthood for the majority of those diagnosed as children. An entire generation of adults with functional impairment went without diagnosis or support because the diagnostic framework did not yet recognize their presentation. A tangent worth noting: racial disparities in ADHD diagnosis run in both directions simultaneously. Black children in the United States have historically been underdiagnosed compared to white children for behavioral health conditions generally, while also being more likely to receive punitive rather than therapeutic responses to the same behaviors. This dual disparity is not a paradox — it reflects different routes through different institutional systems, each with its own bias pattern.

What Pathologizing Normal Variation Actually Means

The strongest version of the overdiagnosis argument — that we are pathologizing normal variation — deserves engagement on its own terms. There is a legitimate philosophical question about where disorder ends and difference begins. The DSM diagnostic criteria require that symptoms cause clinically significant impairment in functioning. In practice, the impairment threshold is not applied consistently, and there are real cases where the diagnosis reflects a mismatch between a child's traits and their educational environment rather than any intrinsic dysfunction. A study from Michigan State University found that among children diagnosed with ADHD in kindergarten, a substantial proportion of diagnoses were concentrated among children who were the youngest in their grade cohort — children whose relative developmental immaturity was being interpreted as pathology. This is strong evidence that some proportion of childhood ADHD diagnoses reflect context-dependent behavioral differences rather than stable neurological conditions.

Holding the Complexity

The honest position on ADHD overdiagnosis is this: yes, diagnostic inconsistency exists and some people receive diagnoses that do not reflect genuine clinical impairment. Yes, industry influence has contributed to diagnostic expansion beyond what clinical evidence justifies. And also: there are millions of people — disproportionately female, disproportionately adult, disproportionately from communities with less clinical access — who need and have not received appropriate diagnosis and support. The overdiagnosis debate that focuses exclusively on excess at the top ignores the deficits at the edges, and the people living in those deficits pay the cost of that selective attention.